Sunshine Biopharma Opens Twitter Account For Increased Shareholder Engagement
27 juil. 2021 09h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, July 27, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer
08 juil. 2021 09h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, July 08, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
BioNTech gibt Dosierung des ersten Patienten mit fortgeschrittenem Melanom in der Phase-2-Studie mit mRNA-basiertem BNT111 bekannt
18 juin 2021 05h00 HE
|
BioNTech SE
Erstes Programm aus BioNTechs unternehmenseigener mRNA-Krebsimpfstoff-Plattform FixVac schreitet voran, sodass Patienten erstmals in einer randomisierten klinischen Phase-2-Studie behandelt...
BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
18 juin 2021 05h00 HE
|
BioNTech SE
First program from BioNTech’s fully-owned mRNA cancer vaccine platform FixVac treats patients in a randomized clinical Phase 2 clinical trial Phase 2 trial is based on positive results from Phase 1...
Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
28 mai 2021 08h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today...
Global Peptide Cancer Vaccine Clinical Trials Research Market Outlook 2026
22 avr. 2021 10h37 HE
|
KuicK Research
DELHI, India, April 22, 2021 (GLOBE NEWSWIRE) -- “Global Peptide Cancer Vaccine Market & Clinical Trials Insight 2026” Report Highlights: Global Peptide Cancer Vaccine Market Trends...
Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine
15 juin 2020 07h15 HE
|
Treos Bio Corp.
LONDON, June 15, 2020 (GLOBE NEWSWIRE) -- Treos Bio Limited, a clinical stage biopharma company developing targeted peptide cancer immunotherapies, today said that it has developed and successfully...
Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation
29 mai 2020 12h17 HE
|
Treos Bio Corp.
LONDON, May 29, 2020 (GLOBE NEWSWIRE) -- Treos Bio Limited, a clinical stage biopharma company developing precision peptide cancer immunotherapies, today presented positive final data from a Phase...
Aldevron Plasmids Used to Support Calviri’s Clinical Trial of a Vaccine Against Canine Cancer
03 déc. 2019 09h51 HE
|
Aldevron
TEMPE, A.Z. and FARGO, N.D., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Prevention of cancer onset is the ultimate aspiration for animals and humans. Cancer is caused by mutations that are specific to the...
Treos Bio Announces Positive Interim Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
28 mai 2019 08h15 HE
|
Treos Bio Corp.
LONDON, May 28, 2019 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, precision cancer vaccines combined with companion diagnostic devices, reported...